Search results for: 'CCAAS space'

This Frost & Sullivan study examines the role of artificial intelligence (AI) in the global mammography market. The high prevalence of breast cancer in women has increased the demand for breast cancer screening, which, in turn, heightened the focus on using AI-based solutions for mammography. AI solutions can reduce results variability among radiol...

This report discusses the important considerations for players in the Bioinformatics market and assists decision making in the Outsourcing space.

This study examines the Turkish medical imaging market. Healthcare reforms focusing on oncology and cardiology as the priority areas has resulted in 80% of medical imaging equipment being purchased by the government. Frost & Sullivan estimates that revenue for computed tomography (CT), magnetic resonance imaging (MRI), and ultrasound (USG) will rea...

The scope of this research study revolves around the global standards for healthcare and medical device interoperability and connectivity. It aims to analyze the impact of standards on sharing of patient information between healthcare IT solutions and medical devices in today’s healthcare system that is increasingly getting connected and digitized....

The research service provides an overview of the application of radio frequency identification (RFID) in the healthcare industry. It specifically focuses on RFID smart cabinet systems that track equipment and medical supplies in a healthcare environment. The study aims to analyse the technological advancements in RFID smart cabinet systems and incl...

01 Jul 2016  |  Europe  |  Market Research

Western Europe Point-of-Care Testing (POCT) Market

Infographics

×

Point-of-care testing is an integral part of the IVD market that is rapidly evolving into a preferred testing mode in the EU region. POCT is a segment that presents growth opportunities for a cross-section of players, ranging from OEMs to data integrators to technology vendors. The stakeholders need to be abreast of the challenges posed by the indu...

Europe’s life sciences sector is approaching a defining inflection point in 2026, as major regulatory and policy reforms converge to reshape pharma, diagnostics, life sciences IT, biotechnology, and the bioeconomy. Together, these frameworks open clear growth pathways across the value chain: the Clinical Trials Regulation (CTR) and European Health ...

01 Mar 2022  |  Europe  |  Market Research

European Clinical Laboratory Services Growth Opportunity

Customer Experience Driven by New B2B and B2C Business Models

Infographics

×

Diagnostics is the backbone of the healthcare sector. According to a World Health Organization (WHO) study, although the segment accounts for less than 5% of hospital costs, its findings influence 60–70% of healthcare decision-making. Diagnostics helps to analyze medical conditions and guide patients toward the right medication, treatment, or surge...

Technology and design improvements in multipurpose R/F Systems, the recent increase in the adoption of fluoroscopy procedures by private healthcare facilities and commercialization of disruptive technologies in real-time R/F are set to boost growth opportunities in the Western European fluoroscopy market. These multi-functional R/F systems have the...